The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BioAge Labs Inc shares valued at $2,501,626 were purchased by Pande Vijay Satyanand on Oct 01 ’24. At $19.73 per share, Pande Vijay Satyanand acquired 126,793 shares. The insider’s holdings grew to 1,026,793 shares worth approximately $4.42 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Pande Vijay Satyanand purchased 67,096 shares, netting a total of over 1,323,804 in proceeds. Following the buying of shares at $19.73 each, the insider now holds 1,093,889 shares.
Before that, Pande Vijay Satyanand had added 25,306 shares to its account. In a trade valued at $503,589, the Director bought BioAge Labs Inc shares for $19.90 each. Upon closing the transaction, the insider’s holdings increased to 25,306 shares, worth approximately $4.81 million.
As published in a research note from Morgan Stanley on December 10, 2024, BioAge Labs Inc [BIOA] has been rated down from an Overweight to an Underweight and the price target has been revised to $5 from $40. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early December. As of December 09, 2024, Citigroup has decreased its “Buy” rating to a “Neutral” for BIOA. Earlier on October 21, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for BIOA stock.
Analyzing BIOA Stock Performance
During the last five days, there has been a drop of approximately -10.42%. Over the course of the year, BioAge Labs Inc shares have dropped approximately -76.52%. Nevertheless, trading volume fell to 4.7 million shares from 0.93 million shares the previous day.
Support And Resistance Levels for BioAge Labs Inc (BIOA)
According to the 24-hour chart, there is a support level at 3.81, which, if violated, would cause prices to drop to 3.31. In the upper region, resistance lies at 4.96. The next price resistance is at 5.61. RSI (Relative Strength Index) is 22.26 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.21, which suggests the price will decrease in the coming days. Percent R is at 97.28%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.